| Literature DB >> 26027991 |
Kyoko Niimi1, Eiichiro Nagata, Naoko Murata, Masako Sato, Jun Tanaka, Yukihiro Horio, Hiroto Takiguchi, Hiromi Tomomatsu, Katsuyoshi Tomomatsu, Naoki Hayama, Tsuyoshi Oguma, Takuya Aoki, Tetsuya Urano, Tadashi Abe, Chie Inomoto, Shunya Takizawa, Koichiro Asano.
Abstract
A 64-year-old man presented with diplopia, muscle weakness, a pulmonary nodule and mediastinal widening on a chest radiograph. He was diagnosed with clinical stage IIIA (T2aN2M0) lung cancer. His neurological symptoms worsened following the initiation of thoracic radiation therapy (60 Gy) and chemotherapy. A diagnosis of myasthenia gravis (MG) was confirmed with a repetitive nerve stimulation test that showed a waning pattern, and a positive edrophonium test, although neither anti-acetylcholine receptor antibodies nor anti-muscle-specific tyrosine kinase antibodies were detected. The ptosis and limb muscle weakness improved with prednisolone and acetylcholinesterase inhibitor treatment, and a partial response of the lung cancer to chemoradiotherapy was obtained. However, the ptosis and limb muscle weakness worsened again following a recurrence of the lung cancer. The herein described case, in which lung cancer and MG occurred and recurred simultaneously, suggests that MG can develop as a paraneoplastic syndrome of lung cancer.Entities:
Mesh:
Substances:
Year: 2015 PMID: 26027991 DOI: 10.2169/internalmedicine.54.3363
Source DB: PubMed Journal: Intern Med ISSN: 0918-2918 Impact factor: 1.271